Purchases and Sales Made in Q4 2024 in Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX) during Q4 2024. The information is specifically focused on institutions that hold shares of CytomX Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 14, 2025
Q4 2024
|
Congress Park Capital LLC
|
SELL
|
- |
-251K- 20.68% |
$216K - $324K
|
965K
$2.23M
|
|
|
Feb 13, 2025
Q4 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-448K- 48.91% |
$385K - $577K
|
467K
$1.08M
|
|
|
Feb 14, 2025
Q4 2024
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-500K- 6.4% |
$430K - $645K
|
7.31M
$16.9M
|
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-759K- 83.96% |
$653K - $979K
|
145K
$335K
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-1.04M- 63.52% |
$898K - $1.35M
|
600K
$1.39M
|